by Jordana Choucair | Aug 24, 2022 | Life Sciences
Moderna submitted a request for the Food and Drug Administration (FDA) to authorize an updated version of its COVID-19 vaccine targeting the latest omicron subvariants. The company said the shots will be ready to ship in September, if the FDA signs off. Moderna’s...
by Jordana Choucair | Aug 24, 2022 | Life Sciences
The Biden administration is planning to launch a COVID-19 booster campaign in September. Reportedly, the FDA is set to authorize updated versions of Pfizer-BioNTech’s and Moderna’s boosters for teenagers and adults around Labor Day. Soon thereafter, the government...
by Jordana Choucair | Aug 23, 2022 | Life Sciences
Pfizer and BioNTech have submitted their application to the Food and Drug Administration (FDA) for emergency use authorization of their updated COVID19 vaccine booster that specifically targets Omicron subvariants BA.4 and BA.5. If approved, the updated vaccine could...
by Jordana Choucair | Aug 22, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved Novavax’s COVID-19 vaccine for emergency use in adolescents, paving the way to expand eligibility for the fourth shot available in the U.S. The two-dose regimen utilizes protein-based technology previously leveraged in...
by Jordana Choucair | Aug 19, 2022 | Life Sciences
The Biden administration announced Danish-based Bavarian Nordic entered into an agreement with U.S.-based contract manufacturer Grand River Aseptic Manufacturing (GRAM) to produce monkeypox vaccines. According to officials, the technology transfer of the production...
by Jordana Choucair | Aug 18, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved Bluebird Bio Inc.’s Zynteglo gene therapy. The approval gives patients suffering from a rare genetic blood disorder called beta-thalassemia a possible cure, at a hefty price. Bluebird, which has priced the...
Recent Comments